Canada · Delayed Price · Currency is CAD K-Bro Linen Earnings Call Transcripts
Fiscal Year 2026
-
Q2 2026 saw 33% revenue growth to CAD 150.4 million, driven by the Stellar Mayan acquisition and price increases. Healthcare revenue surged 50%, and 40% of targeted synergies from Stellar have been achieved. Margins remain resilient despite energy cost pressures.
-
The meeting highlighted strong revenue and EBITDA growth driven by acquisitions, stable dividends, and a focus on expanding in Canada and the U.K. All directors and auditors were reappointed, and the company emphasized its ESG commitments and strategic growth plans.
-
Q1 2026 saw record revenue and EBITDA, driven by the Stellar Mayan acquisition and steady organic growth. Margins remain strong despite energy cost pressures, with integration synergies progressing and leverage declining as expected.
Fiscal Year 2025
-
Record 2025 results driven by acquisitions and strong healthcare growth, with revenue up 36% and adjusted EBITDA up 37%. Integration of Stellar Mayan is on track, and 2026 guidance calls for stable margins, strong cash flow, and continued focus on growth and operational efficiencies.
-
Record Q3 results driven by Stellar Mayan acquisition, with revenue up 49% and adjusted EBITDA up 46%. Canadian and U.K. platforms now balanced, with strong healthcare and hospitality growth and positive outlook for 2026.
-
Record Q2 2025 results driven by acquisitions and strong healthcare and hospitality growth, with revenue up 21% and adjusted EBITDA up 30% year-over-year. Stellar Mayan integration underway, margins expected to remain stable, and liquidity remains strong.
-
The meeting confirmed strong financial growth in 2024, with revenue up 16% and adjusted EBITDA up 24%. Key strategic moves included the acquisition of Star Mayan, expanding the U.K. footprint and balancing the revenue mix. All resolutions, including director elections and auditor reappointment, were approved.
Fiscal Year 2024
-
Record 2024 results with revenue up 16% and Adjusted EBITDA up 24%, driven by acquisitions and strong hospitality growth. Margins improved, debt rose due to M&A, and outlook for 2025 remains positive with stable margins and continued focus on organic and acquisition-led growth.
-
Record Q3 results driven by acquisitions and strong hospitality growth, with revenue up 20% and Adjusted EBITDA up 27%. Margins improved, and the outlook calls for steady mid-single-digit organic growth and continued M&A activity.
-
Record Q2 results driven by strong growth in both healthcare and hospitality, boosted by acquisitions and price increases. Adjusted EBITDA and margins improved, with a positive outlook and disciplined M&A strategy. Integration of recent acquisitions is progressing smoothly.
-
The meeting confirmed the election of directors and auditor appointment, reviewed strong 2023 financial results with significant revenue and EBITDA growth, and outlined ongoing acquisition-driven expansion and sustainability initiatives. Dividends remain stable, and the company maintains a strong liquidity position.